Multiple myelomas (MM) is a plasma cell malignancy that accounts for approximately 10% of all hematological malignancies. Many new drugs…
Immunomodulatory agents (IMiDs) are a class of immunomodulatory drugs. Thalidomide analogs have induced significant antimyeloma effects via immune-modulation, antiangiogenesis, and…